Alexios Iliopoulos

Psoriasis induced by anti–tumor necrosis factor therapy: A paradoxical adverse reaction

P.P. Sfikakis, Alexios Iliopoulos, Antonia Elezoglou et al. · Arthritis & Rheumatism · 2005 · 299 citations

Successful treatment of refractory adult-onset Still?s disease with infliximab. A prospective, non-comparative series of four patients

Alexander Kokkinos, Alexios Iliopoulos, Paraskevi Greka et al. · Clinical Rheumatology · 2004 · 96 citations

Rheumatology, Refractory Adult-onset, Non-comparative Series +6

Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival

Irini Flouri, Theodora E. Markatseli, Paraskevi V. Voulgari et al. · Seminars in Arthritis and Rheumatism · 2013 · 92 citations

Rheumatoid Disorder, Rheumatology, Medicine +10

Comparative Analysis and Predictors of 10-year Tumor Necrosis Factor Inhibitors Drug Survival in Patients with Spondyloarthritis: First-year Response Predicts Longterm Drug Persistence

Irini Flouri, Theodora E. Markatseli, Kyriaki Boki et al. · The Journal of Rheumatology · 2018 · 56 citations · Full text

Increased levels of soluble TNF-like cytokine 1A in ankylosing spondylitis

Maria Konsta, Giorgos Bamias, Maria G. Tektonidou et al. · Lara D. Veeken · 2012 · 41 citations · Full text